PlainPharmaWatch

CMS Open Payments · Program Year 2024

Biobeat USA Inc.

Biobeat USA Inc. reported $11,552.38 in payments to 85 physicians and teaching hospitals across 85 transactions.

See the rankings → How this is sourced
$11.6K
Total payments
85
Transactions
85
Recipients
#1623
of 1,925 companies

Biobeat USA Inc. reported $11,552.38 in payments to 85 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1623 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $135.91 per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Biobeat USA Inc. pairs modest payment volume with a concentrated payment pattern focused on a handful of top recipients.

#1623
of 1,925 companies
0.0%
of all US industry payments
0.7%
paid to its single top recipient
2
payment categories

How Biobeat USA Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Biobeat USA Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$11,552 16th percentile higher than 16% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). This entry sits in this band. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Biobeat USA Inc.

$11,552.38: that is what Biobeat USA Inc. reported in payments to 85 physicians and teaching hospitals during Program Year 2024, spread across 85 transactions ($135.91 per transaction, $135.91 per recipient). The company sits at rank #1623 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $8.9K across 3 transactions, 76.8% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 2 types of general payments, Biobeat USA Inc.'s largest category was "Consulting Fee" at $8.9K - 76.8% of the company's reported total.

How Biobeat USA Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$8.9K2. Food and Beverage$2.7K
Payment Type Amount Transactions
Consulting Fee $8.9K 3
Food and Beverage $2.7K 82

Recipient Concentration in General Payments

The five largest recipient relationships account for $9,138.30 (79.1%) of $11,552.38 in this company's General Payments records across 81 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Biobeat USA Inc.

The five named recipients with the highest reported General Payments from this company

Amir Lerman$8.0KOren J MECHANIC$875.00Kunal Manmohan Patel$100.00Megan Hammer$81.65Dustin Bartlett$81.65
  1. 1

    Amir Lerman

    $8,000.00 across 2 reported transactions

  2. 2

    Oren J MECHANIC

    $875.00 across 1 reported transactions

  3. 3

    Kunal Manmohan Patel

    $100.00 across 1 reported transactions

  4. 4

    Megan Hammer

    $81.65 across 1 reported transactions

  5. 5

    Dustin Bartlett

    $81.65 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $135.91. Average per recipient: $135.91.

Total Amount

$11,552.38

Avg per Transaction

$135.91

Avg per Recipient

$135.91

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Biobeat USA Inc. Share

0.0%

#1623 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Biobeat USA Inc.

Biolase MG LLC

$11.5K 13 recipients

Greiner Bio-One North America, Inc.

$11.6K 33 recipients

EnableCV Inc.

$11.6K 73 recipients

Xenco Medical LLC

$11.5K 5 recipients

Hoya Surgical Optics, Inc

$11.7K 5 recipients

Maxx Health Inc

$11.5K 27 recipients

Frequently Asked Questions

How much did Biobeat USA Inc. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Biobeat USA Inc., totaling $11,552.38 across 85 transactions to physicians and hospitals.
How many physicians received payments from Biobeat USA Inc.? ▾
85 physicians and teaching hospitals received payments from Biobeat USA Inc. in 2024, averaging $135.91 per recipient.
What types of payments did Biobeat USA Inc. make? ▾
2 categories of general payment make up Biobeat USA Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $8.9K, representing 76.8% of the company's reported total.
How does Biobeat USA Inc. rank among pharmaceutical companies? ▾
By total payment amount, Biobeat USA Inc. sits at #1623 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Biobeat USA Inc.? ▾
The average transaction from Biobeat USA Inc. was $135.91 in 2024. The company made 85 total transactions to 85 recipients.
Where does the payment data for Biobeat USA Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Biobeat USA Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.